[HTML][HTML] Glioblastoma treatment modalities besides surgery

H Zhang, R Wang, Y Yu, J Liu, T Luo, F Fan - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Glioblastoma multiforme (GBM) is commonly known as the most aggressive primary CNS
tumor in adults. The mean survival of it is 14 to 15 months, following the standard therapy …

Metronomic chemotherapy and immunotherapy in cancer treatment

YL Chen, MC Chang, WF Cheng - Cancer letters, 2017 - Elsevier
Systemic chemotherapy given at maximum tolerated doses (MTD) has been the mainstay of
cancer treatment for more than half a century. In some chemosensitive diseases such as …

Application of evolutionary principles to cancer therapy

PM Enriquez-Navas, JW Wojtkowiak, RA Gatenby - Cancer research, 2015 - AACR
The dynamic cancer ecosystem, with its rich temporal and spatial diversity in environmental
conditions and heritable cell phenotypes, is remarkably robust to therapeutic perturbations …

The evolution and ecology of resistance in cancer therapy

R Gatenby, J Brown - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Despite continuous deployment of new treatment strategies and agents over many decades,
most disseminated cancers remain fatal. Cancer cells, through their access to the vast …

Adjuvant capecitabine following concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a randomized clinical trial

J Miao, L Wang, SH Tan, J Li, J Yi, EHW Ong… - JAMA …, 2022 - jamanetwork.com
Importance Induction or adjuvant chemotherapy with concurrent chemoradiotherapy (CCRT)
are first-line treatment options for treatment of locoregionally advanced nasopharyngeal …

Management of recurrent nasopharyngeal carcinoma: current perspectives

F Perri, G Della Vittoria Scarpati… - OncoTargets and …, 2019 - Taylor & Francis
Nasopharyngeal carcinoma is a rare disease in Western countries. Nevertheless, its
incidence in China, Singapore, and other Eastern countries reaches 20 cases per 100,000 …

[HTML][HTML] Precision meets repurposing: Innovative approaches in human papillomavirus and Epstein-Barr virus-driven cancer therapy

Q Fernandes - Cancer Letters, 2024 - Elsevier
Viral malignancies represent a distinct entity among cancers. Oncoviruses like the Human
Papilloma Virus (HPV) and the Epstein Barr Virus (EBV) are highly potent inducers of …

[HTML][HTML] A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy

R Maharjan, JU Choi, S Kweon, R Pangeni, NK Lee… - Biomaterials, 2022 - Elsevier
In this study, we investigated the immune-modulating effects of a novel metronomic
chemotherapy (MCT) featuring combined oral oxaliplatin (OXA) and pemetrexed (PMX) for …

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

X Huo, J Li, F Zhao, D Ren, R Ahmad, X Yuan, F Du… - BMC cancer, 2021 - Springer
Background The role of capecitabine in neoadjuvant and adjuvant chemotherapy for early-
stage triple-negative breast cancer (TNBC) is highly controversial. Our meta-analysis was …

[HTML][HTML] Immunotherapeutic approaches for hepatocellular carcinoma

V Longo, A Gnoni, AC Gardini, S Pisconti, A Licchetta… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the
diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment …